Compare Amer Sports Inc (AS) vs Oscar Health Inc (OSCR) Price & Performance

Amer Sports (AS) trades at $33.03, down 8.68% in the past 24 hours, with a bearish technical signal from moving averages. The company reported strong Q1 2026 earnings of $0.38 per share, beating estimates, and raised full-year guidance. Revenue grew 32% year-over-year to $1.95 billion, driven by Arc'teryx and Salomon. Valuation ratios include a P/E of 42.3 and P/S of 2.8. Net income margin stands at 6.5% for 2025.

The outlook is positive due to consistent earnings beats and raised guidance, but high valuation and technical bearishness pose risks. Analyst consensus is strongly bullish with a $58.67 price target, suggesting significant upside. Key risks include reliance on brand momentum and market volatility. Investors should weigh strong fundamentals against current technical weakness.

Oscar Health (OSCR) trades at $29.61, up 7.01% today, with technical indicators showing a bearish trend but oversold RSI signals. The company reported strong Q2 2026 earnings, beating EPS estimates with $1.1 per share, and raised its full-year outlook amid membership growth and cost control. Revenue surged 70% year-over-year to $4.9 billion for the first half of 2026, driving a net income turnaround to $551 million for the full year 2026.

The outlook is positive with robust revenue growth and profitability improvements, though risks include competitive pressures and reliance on Obamacare policies. Analysts have a consensus price target of $32.50, suggesting moderate upside, but hold ratings dominate due to execution risks.